The deal aims to streamline the payment process for users, allowing Medable to take payment through Google Cloud Marketplace. Credit: Shutterstock / T. Schneider

California-based clinical development company Medable has announced a partnership with technology giant Google Cloud to bring the company’s digital, decentralised clinical trial platform to the Google Cloud Marketplace.

Medable says that offering its platform on the Google Cloud service will allow users to benefit from Google Cloud infrastructure and online by taking advantage of artificial intelligence (AI) and advanced cloud technologies to accelerate trial design, execution, and data management. The company also insisted that its Google-hosted platform will come equipped with Studio, the company’s latest clinical trial organisation software, offered through a software-as-a-service system.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Michelle Longmire, co-founder, and CEO of Medable, said: “This alliance provides life sciences companies with Medable’s cutting-edge clinical development technology powered by Google Cloud through Google Cloud Marketplace.

“The collaboration will enable scaled and seamless adoption of Medable solutions by Google Cloud users, providing life sciences companies with platform capabilities proven to improve patient access to trials and accelerate critical development efforts, globally.”

Additionally, the deal aims to streamline the payment process for users, allowing Medable to take payment through Google Cloud Marketplace, benefiting from consolidated billing and streamlined procurement. Medable usage will appear directly on Google Cloud invoices, and users will be able to pay for a portion of this usage with their committed Google Cloud spend.

See Also:

The announcement follows a year after Medable partnered with the Clinical Trials Center of the Boston-based Brigham and Women’s Hospital and Harvard (MRCT Center) to release a toolkit for the decentralised clinical trial (DCT) ethics review process. Now Medable says it has deployed its software-as-a-service platform in more than 300 decentralised  and hybrid clinical trials in 60 countries covering approximately a million patients so far.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Dai Vu, managing director of Google Cloud Marketplace, said: “Bringing Medable’s platform to Google Cloud Marketplace will help customers quickly deploy, manage, and expand their use of the AI-driven clinical trial platform on Google Cloud’s trusted, global infrastructure.”

The announcement also follows after Medable’s system was selected by the Nova Scotia Health Innovation Hub to improve care accessibility for remote oncology patients in rural Canada.